comparemela.com

Latest Breaking News On - அமிரா மருந்துகள் - Page 1 : comparemela.com

After their startups were acquired, 3 biotech executives try a second act with San Diego s 858 Therapeutics

After their startups were acquired, 3 biotech executives try a second act with San Diego s 858 Therapeutics
sandiegouniontribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegouniontribune.com Daily Mail and Mail on Sunday newspapers.

New leaders for Swiss tech startups Startupticker ch | The Swiss Startup News channel

The Zurich-based startup offering a forecasting tool for the foodservice industry has made changes in its leadership. Former CTO Roman Lickel is now the company’s Managing Director. Roman takes over the role from Simon Michel, with whom he built Prognolite. “The last few years have been an incredibly intense and beautiful time. Although I believe in success more than ever, I see that Prognolite can be better led by my co-founder Roman together with Nico with the somewhat changed focus. As a shareholder, however, I will remain closely connected to Prognolite,” says Simon.  For its platform that allows over 40,000 tenants to rent everyday objects, Sharely has welcomed Lucie Rein as its new CEO to further grow Sharely as a leading sharing platform. Lucie brings several years of experience having worked at companies such as the startups Farmy and Too Good To Go and leading global companies Barilla and Nestlé, Danone and Ikea. Sharely has seen remarkable growth since its foundat

Kinarus further strengthens its leadership with two reputed industry experts

Kinarus further strengthens its leadership with two reputed industry experts EQS Group-News: Kinarus AG / Key word(s): Personnel/Private Equity 26.04.2021 / 07:01 Hari Kumar, former CEO of Adheron Therapeutics, Inc. appointed Chairman of the Board of Directors Thierry Fumeaux, MD, former member of Swiss National Covid Taskforce, joined Kinarus as new Chief Medical Officer Basel, Switzerland, April 26, 2021. Kinarus AG, a Swiss clinical-stage biopharmaceutical company and owner of KIN001, a differentiated therapeutic candidate for the treatment of multiple diseases with high unmet need, announced today the appointment of Hari Kumar as Chairman of the Board of Directors and Thierry Fumeaux as Chief Medical Officer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.